Ligand profile
CHEMBL1303009
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_5016 — putative acid phosphatase Wzb
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1303009- UniProt (similar protein)
P24666- Target protein
- VK055_5016
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 36.4
- −1 ≤ LogP ≤ 5 3.49
- MW ≤ 500 Da 256.3
- LogP ≤ 5 3.49
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 36.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1cc(N2CCC(C)CC2)nc2cccc(O)c12Cc1cc(N2CCC(C)CC2)nc2cccc(O)c12
InChI=1S/C16H20N2O/c1-11-6-8-18(9-7-11)15-10-12(2)16-13(17-15)4-3-5-14(16)19/h3-5,10-11,19H,6-9H2,1-2H3InChI=1S/C16H20N2O/c1-11-6-8-18(9-7-11)15-10-12(2)16-13(17-15)4-3-5-14(16)19/h3-5,10-11,19H,6-9H2,1-2H3
WKUJMDZEOHQASN-UHFFFAOYSA-NWKUJMDZEOHQASN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- active
- Binding sites
- PF01451
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1303009 →
- UniProt UniProt P24666 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1303009”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_5016.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).